Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,181 to 2,200 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. | Sci Rep | 2021 | 33479306 | PubTator, text mining | PubMed |
| Transcriptional and functional characterization of neonatal circulating Innate Lymphoid Cells. | Stem Cells Transl Med | 2021 | 33475258 | PubTator, text mining | PubMed |
| Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages. | Cell Res | 2021 | 33473155 | PubTator, text mining | PubMed |
| Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer. | Signal Transduct Target Ther | 2021 | 33473101 | PubTator, text mining | PubMed |
| Human mesenchymal stem cell therapy promotes retinal ganglion cell survival and target reconnection after optic nerve crush in adult rats. | Stem Cell Res Ther | 2021 | 33468246 | PubTator, text mining | PubMed |
| Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma. | Pharmaceutics | 2021 | 33466892 | PubTator, text mining | PubMed |
| Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma. | Clin Transl Med | 2021 | 33463068 | PubTator, text mining | PubMed |
| Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. | Elife | 2021 | 33459589 | PubTator, text mining | PubMed |
| Antibodies to watch in 2021. | MAbs | 2021 | 33459118 | PubTator, text mining | PubMed |
| Perlecan in the Natural and Cell Therapy Repair of Human Adult Articular Cartilage: Can Modifications in This Proteoglycan Be a Novel Therapeutic Approach? | Biomolecules | 2021 | 33450893 | PubTator, text mining | PubMed |
| Discovery of core gene families associated with liver metastasis in colorectal cancer and regulatory roles in tumor cell immune infiltration. | Transl Oncol | 2021 | 33450702 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges. | J Cancer | 2021 | 33442419 | PubTator, text mining | PubMed |
| Invariant natural killer T cells balance B cell immunity. | Immunol Rev | 2021 | 33438287 | PubTator, text mining | PubMed |
| Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. | Nat Rev Clin Oncol | 2021 | 33437048 | PubTator, text mining | PubMed |
| Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges. | J Natl Cancer Inst | 2021 | 33432320 | PubTator, text mining | PubMed |
| Fibroblast Subsets in Intestinal Homeostasis, Carcinogenesis, Tumor Progression, and Metastasis. | Cancers (Basel) | 2021 | 33430285 | PubTator, text mining | PubMed |
| Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions. | Int J Mol Sci | 2021 | 33430234 | PubTator, text mining | PubMed |
| Immune-Checkpoint Inhibitors in B-Cell Lymphoma. | Cancers (Basel) | 2021 | 33430146 | PubTator, text mining | PubMed |
| A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling. | Aging (Albany NY) | 2021 | 33429364 | PubTator, text mining | PubMed |
| The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer. | Aging (Albany NY) | 2021 | 33428603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=110